Inhibiting the histone reader function of its PHD finger domain can reverse the oncogenic effects of NUP98-PHF23, revealing potential new therapeutic targets for AML (Gough et al., 2014; Ning, 2016; Ahn et al., 2025). Here, PHF23 is linked to acute myeloid leukemia.